Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 8417190, 10 pages
http://dx.doi.org/10.1155/2016/8417190
Research Article

Upregulation of Soluble HLA-G in Chronic Left Ventricular Systolic Dysfunction

1Department of Cardiology, Zealand University Hospital (Roskilde), 10 Sygehusvej, 4000 Roskilde, Denmark
2Department of Clinical Biochemistry, Centre for Immune Regulation and Reproductive Immunology (CIRRI), Zealand University Hospital (Roskilde) and Department of Clinical Medicine, University of Copenhagen, 10 Sygehusvej, 4000 Roskilde, Denmark

Received 19 May 2016; Revised 20 July 2016; Accepted 25 August 2016

Academic Editor: Enrico Fainardi

Copyright © 2016 Line Lisbeth Olesen and Thomas Vauvert F. Hviid. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Ponikowski, A. A. Voors, S. D. Anker et al., “2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC,” European Heart Journal, vol. 37, no. 27, pp. 2129–2200, 2016. View at Publisher · View at Google Scholar
  2. L. L. Olesen, A. Andersen, and S. Thaulow, “Hand-held echocardiography is useful for diagnosis of left systolic dysfunction in an elderly population,” Danish Medical Journal, vol. 62, no. 7, Article ID A5100, pp. 1–5, 2015. View at Google Scholar · View at Scopus
  3. A. Mosterd and A. W. Hoes, “Clinical epidemiology of heart failure,” Heart, vol. 93, no. 9, pp. 1137–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Gullestad, T. Ueland, L. E. Vinge, A. Finsen, A. Yndestad, and P. Aukrust, “Inflammatory cytokines in heart failure: mediators and markers,” Cardiology, vol. 122, no. 1, pp. 23–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Maisel, C. Mueller, K. Adams Jr. et al., “State of the art: using natriuretic peptide levels in clinical practice,” European Journal of Heart Failure, vol. 10, no. 9, pp. 824–839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. L. Olesen and A. Andersen, “ECG as a first step in the detection of left ventricular systolic dysfunction in the elderly,” ESC Heart Failure, vol. 3, no. 1, pp. 44–52, 2016. View at Publisher · View at Google Scholar
  7. C. Ruggiero, A. Cherubini, A. Ble et al., “Uric acid and inflammatory markers,” European Heart Journal, vol. 27, no. 10, pp. 1174–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. S. Filippatos, M. I. Ahmed, J. D. Gladden et al., “Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data,” European Heart Journal, vol. 32, no. 6, pp. 712–720, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Lippi, M. Montagnana, M. Franchini, E. J. Favaloro, and G. Targher, “The paradoxical relationship between serum uric acid and cardiovascular disease,” Clinica Chimica Acta, vol. 392, no. 1-2, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Leyva, S. D. Anker, I. F. Godsland et al., “Uric acid in chronic heart failure: a marker of chronic inflammation,” European Heart Journal, vol. 19, no. 12, pp. 1814–1822, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. D. L. Mann, “Innate immunity and the failing heart. The cytokine hypothesis revisited,” Circulation Research, vol. 116, no. 7, pp. 1254–1268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Oikonomou, D. Tousoulis, G. Siasos, M. Zaromitidou, A. G. Papavassiliou, and C. Stefanadis, “The role of inflammation in heart failure: new therapeutic approaches,” Hellenic Journal of Cardiology, vol. 52, no. 1, pp. 30–40, 2011. View at Google Scholar · View at Scopus
  13. T. V. F. Hviid, “HLA-G in human reproduction: aspects of genetics, function and pregnancy complications,” Human Reproduction Update, vol. 12, no. 3, pp. 209–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. H. Larsen and T. V. F. Hviid, “Human leukocyte antigen-G polymorphism in relation to expression, function, and disease,” Human Immunology, vol. 70, no. 12, pp. 1026–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. A. Donadi, E. C. Castelli, A. Arnaiz-Villena, M. Roger, D. Rey, and P. Moreau, “Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association,” Cellular and Molecular Life Sciences, vol. 68, no. 3, pp. 369–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. D. Carosella, N. Rouas-Freiss, D. T.-L. Roux, P. Moreau, and J. LeMaoult, “HLA-G. an immune checkpoint molecule,” Advances in Immunology, vol. 127, pp. 33–144, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Sheshgiri, N. Rouas-Freiss, V. Rao et al., “Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients,” The Journal of Heart and Lung Transplantation, vol. 27, no. 5, pp. 522–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Rouas-Freiss, P. Moreau, J. LeMaoult, and E. D. Carosella, “The dual role of HLA-G in cancer,” Journal of Immunology Research, vol. 2014, Article ID 359748, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. L. L. Nilsson, S. Djurisic, and T. V. F. Hviid, “Controlling the immunological crosstalk during conception and pregnancy: HLA-G in reproduction,” Frontiers in Immunology, vol. 5, article 198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Djurisic and T. V. F. Hviid, “HLA class Ib molecules and immune cells in pregnancy and preeclampsia,” Frontiers in Immunology, vol. 5, article 652, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Rebmann, J. Regel, D. Stolke, and H. Grosse-Wilde, “Secretion of sHLA-G molecules in malignancies,” Seminars in Cancer Biology, vol. 13, no. 5, pp. 371–377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Ishitani and D. E. Geraghty, “Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 9, pp. 3947–3951, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Park, S. Lee, B. Park et al., “Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis,” Biochemical and Biophysical Research Communications, vol. 313, no. 3, pp. 606–611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Almasood, R. Sheshgiri, J. M. Joseph et al., “Human leukocyte antigen-G is upregulated in heart failure patients: a potential novel biomarker,” Human Immunology, vol. 72, no. 11, pp. 1064–1067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Djurisic, A. E. Sørensen, and T. V. F. Hviid, “A fast and easy real-time PCR genotyping method for the HLA-G 14-bp insertion/deletion polymorphism in the 3′ untranslated region,” Tissue Antigens, vol. 79, no. 3, pp. 186–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Bortolotti, V. Gentili, L. Melchiorri, A. Rotola, and R. Rizzo, “An accurate and reliable real time SNP genotyping assay for the HLA-G + 3142 bp C > G polymorphism,” Tissue Antigens, vol. 80, pp. 259–262, 2012. View at Publisher · View at Google Scholar
  27. W. H. Hall, R. Ramachandran, S. Narayan, A. B. Jani, and S. Vijayakumar, “An electronic application for rapidly calculating Charlson comorbidity score,” BMC Cancer, vol. 4, article 94, pp. 1–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. V. F. Hviid, R. Rizzo, O. B. Christiansen, L. Melchiorri, A. Lindhard, and O. R. Baricordi, “HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms,” Immunogenetics, vol. 56, no. 3, pp. 135–141, 2004. View at Google Scholar · View at Scopus
  29. X.-Y. Chen, W.-H. Yan, A. Lin, H.-H. Xu, J.-G. Zhang, and X.-X. Wang, “The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma,” Tissue Antigens, vol. 72, no. 4, pp. 335–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Rizzo, D. Bortolotti, N. Ben Fredj et al., “Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis,” Human Immunology, vol. 73, no. 11, pp. 1140–1146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Zebrack and J. L. Anderson, “The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease,” Current Cardiology Reports, vol. 4, no. 4, pp. 278–288, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Stumpf, K. Seybold, S. Petzi et al., “Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction,” European Journal of Heart Failure, vol. 10, no. 8, pp. 733–739, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. M. Ridker and T. F. Lüscher, “Anti-inflammatory therapies for cardiovascular disease,” European Heart Journal, vol. 35, no. 27, pp. 1782–1791, 2014. View at Publisher · View at Google Scholar · View at Scopus